Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
32145 | 112 | 31.5 | 35% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MIDWIFERY MED ASSISTING | Address | 2 | 67% | 2% | 2 |
2 | CLOSED LOOP APPROACH | Author keyword | 1 | 50% | 1% | 1 |
3 | FUNCT GENOM BIO CHIPS | Address | 1 | 50% | 1% | 1 |
4 | PNEUMOCYSTIS JIROVECI INFECTION | Author keyword | 1 | 50% | 1% | 1 |
5 | STEM CELL THERAPEUTICS | Author keyword | 1 | 50% | 1% | 1 |
6 | Z RING ADAPTER | Author keyword | 1 | 50% | 1% | 1 |
7 | METACRESOL | Author keyword | 0 | 33% | 1% | 1 |
8 | ORTHODOX SPIRITUALITY | Author keyword | 0 | 33% | 1% | 1 |
9 | ETH PUBL HEALTHCARE POLICIES | Address | 0 | 25% | 1% | 1 |
10 | KRKA DD | Address | 0 | 25% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLOSED LOOP APPROACH | 1 | 50% | 1% | 1 | Search CLOSED+LOOP+APPROACH | Search CLOSED+LOOP+APPROACH |
2 | PNEUMOCYSTIS JIROVECI INFECTION | 1 | 50% | 1% | 1 | Search PNEUMOCYSTIS+JIROVECI+INFECTION | Search PNEUMOCYSTIS+JIROVECI+INFECTION |
3 | STEM CELL THERAPEUTICS | 1 | 50% | 1% | 1 | Search STEM+CELL+THERAPEUTICS | Search STEM+CELL+THERAPEUTICS |
4 | Z RING ADAPTER | 1 | 50% | 1% | 1 | Search Z+RING+ADAPTER | Search Z+RING+ADAPTER |
5 | METACRESOL | 0 | 33% | 1% | 1 | Search METACRESOL | Search METACRESOL |
6 | ORTHODOX SPIRITUALITY | 0 | 33% | 1% | 1 | Search ORTHODOX+SPIRITUALITY | Search ORTHODOX+SPIRITUALITY |
7 | MOLECULAR EMBRYOLOGY | 0 | 25% | 1% | 1 | Search MOLECULAR+EMBRYOLOGY | Search MOLECULAR+EMBRYOLOGY |
8 | ADAPTIVE REGION OF INTEREST | 0 | 20% | 1% | 1 | Search ADAPTIVE+REGION+OF+INTEREST | Search ADAPTIVE+REGION+OF+INTEREST |
9 | AZATHIOPRINE THERAPY | 0 | 20% | 1% | 1 | Search AZATHIOPRINE+THERAPY | Search AZATHIOPRINE+THERAPY |
10 | SULFAMETROLE | 0 | 20% | 1% | 1 | Search SULFAMETROLE | Search SULFAMETROLE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LAYERED EXCIPIENT SUPPOSITORIES | 0 | 33% | 1% | 1 |
2 | RECEPTOR ALPHA AGONIST | 0 | 11% | 1% | 1 |
3 | CO SOLTRIM | 0 | 100% | 1% | 1 |
4 | LANOSTEROL DEVELOPMENT | 0 | 100% | 1% | 1 |
5 | SULFAMETROL TRIMETHOPRIM | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence | 2011 | 3 | 51 | 25% |
DRUG-THERAPY IN PATIENTS UNDERGOING HEMODIALYSIS - CLINICAL PHARMACOKINETIC CONSIDERATIONS | 1984 | 99 | 40 | 18% |
DRUG-DOSAGE IN END-STAGE RENAL-DISEASE (ESRD) PATIENTS UNDERGOING HEMODIALYSIS - A PREDICTIVE STUDY BASED ON A MICROCOMPUTER PROGRAM | 1993 | 1 | 7 | 43% |
Influence of fever on the pharmacokinetics of ciprofloxacin | 1999 | 4 | 10 | 10% |
Emphasizing the need to more fully understand development: a stem cells and regenerative medicine meeting report | 2007 | 1 | 15 | 7% |
BIBLIOGRAPHY OF RECENT LITERATURE IN SLEEP RESEARCH | 1986 | 0 | 190 | 4% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MIDWIFERY MED ASSISTING | 2 | 67% | 1.8% | 2 |
2 | FUNCT GENOM BIO CHIPS | 1 | 50% | 0.9% | 1 |
3 | ETH PUBL HEALTHCARE POLICIES | 0 | 25% | 0.9% | 1 |
4 | KRKA DD | 0 | 25% | 0.9% | 1 |
5 | NEPHROL HEMODIALYSIS SERV | 0 | 20% | 0.9% | 1 |
6 | BIOMOL STRUCT L14 | 0 | 100% | 0.9% | 1 |
7 | CHICAGO DIST OFF | 0 | 100% | 0.9% | 1 |
8 | MED CLIN GERIATR GERONTOL 5 | 0 | 100% | 0.9% | 1 |
9 | NUCLEO UNIV REINA MERCEDES | 0 | 100% | 0.9% | 1 |
10 | UNIT OPHTHAMOL | 0 | 100% | 0.9% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000168028 | WOOD CREOSOTE//SEIROGAN//ANTIMOTILITY |
2 | 0.0000124854 | CYP ISOZYMES//MOL RECOGNIT TECHNOL DEV IDM//CIENCIAS BASICAS FARMACEUT |
3 | 0.0000069496 | DRUG INDUCED ASEPTIC MENINGITIS//IBUPROFEN TOXICITY//MED PHARM CLIN PHARM |
4 | 0.0000065708 | FOSFOMYCIN RESISTANCE//FOSFOMYCIN//AREA PROD PORCINA |
5 | 0.0000060314 | ZOLPIDEM//ZOPICLONE//ZALEPLON |
6 | 0.0000060232 | AMINOGLYCOSIDES//AMIKACIN//TOBRAMYCIN |
7 | 0.0000056085 | SUICIDE BY COP//POLICE ASSISTED SUICIDE//OFFICER INVOLVED SHOOTINGS |
8 | 0.0000055497 | AGR PROD UTILIZAT//DL BUTHIONINE SULFOXIMINE//DRUG METAB PHARMACOKINET PD TOXICOL |
9 | 0.0000054159 | JAPANESE BRAZILIANS//JAPANESE MIGRANTS//PREVALENCE OF DIABETES |
10 | 0.0000050692 | BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV |